FG-3019 anti-connective tissue growth factor monoclonal antibody: results of an open-label clinical trial in idiopathic pulmonary fibrosis
Raghu, Ganesh, Scholand, Mary Beth, de Andrade, João, Lancaster, Lisa, Mageto, Yolanda, Goldin, Jonathan, Brown, Kevin K, Flaherty, Kevin R, Wencel, Mark, Wanger, Jack, Neff, Thomas, Valone, Frank, Stauffer, John, Porter, Seth
Published in The European respiratory journal (01.05.2016)
Published in The European respiratory journal (01.05.2016)
Get full text
Journal Article
Using forced vital capacity (FVC) in the clinic to monitor patients with idiopathic pulmonary fibrosis (IPF): pros and cons
Nathan, Steven D., Wanger, Jack, Zibrak, Joseph D., Wencel, Mark L., Burg, Cindy, Stauffer, John L.
Published in Expert review of respiratory medicine (01.02.2021)
Published in Expert review of respiratory medicine (01.02.2021)
Get full text
Journal Article
Real-World Practice Patterns for Prevention and Management of Potential Adverse Events with Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
Wencel, Mark L., Haselkorn, Tmirah, Limb, Susan L., Stauffer, John L., Morgenthien, Elizabeth, Raimundo, Karina, LaCamera, Peter P.
Published in Pulmonary therapy (01.06.2018)
Published in Pulmonary therapy (01.06.2018)
Get full text
Journal Article
PIRFENIDONE ADVERSE EVENT MANAGEMENT USING DOSE MODIFICATIONS IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS: RESULTS FROM AN ONLINE, SELF-ADMINISTERED SURVEY
Wencel, Mark, LaCamera, Peter, Stauffer, John, Haselkorn, Tmirah, Yang, Ming, Burg, Cindy
Published in Chest (01.10.2019)
Published in Chest (01.10.2019)
Get full text
Journal Article
PHYSICIAN CHARACTERISTICS AND TREATMENT STRATEGIES BY PIRFENIDONE DISCONTINUATION RATES IN IDIOPATHIC PULMONARY FIBROSIS: RESULTS FROM AN ONLINE, SELF-ADMINISTERED SURVEY
WENCEL, MARK, LIMB, SUSAN, HASELKORN, TMIRAH, MORGENTHIEN, ELIZABETH, YANG, MING, STAUFFER, JOHN, LACAMERA, PETER
Published in Chest (01.10.2018)
Published in Chest (01.10.2018)
Get full text
Journal Article